NEW YORK (GenomeWeb) – Skyline Medical announced on Tuesday that it has agreed to take up to a 25 percent equity stake in partner Helomics.

Under the terms of the deal, Skyline will acquire preferred stock convertible into 20 percent of Helomics' outstanding common shares in exchange for 1.1 million newly issued Skyline shares. Skyline also has the right to convert a previously issued $500,000 loan to privately held Helomics into a 5 percent stake.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Jun
05

This webinar will discuss how Sanofi used literature mining to annotate the association of human leukocyte antigen (HLA) alleles with diseases and drug hypersensitivity as part of a multiple sclerosis (MS) biomarker discovery project.

Jun
14

This webinar will discuss an effort underway at the University of North Carolina Medical Center's to overcome limitations in the hematological genomic testing workflow with artificial intelligence (AI) from Sophia Genetics.